Scholarlink

Background and Aims <p>Iron overload causes symptoms, which can (if not treated) damage organs and systems of the body. We report a Slovakian female patient with chronic anemia and neuropathy due to iron overloading.</p> Methods and Results <p>Clinical workup included laboratory investigations, body imaging, and genetic study. Patients’ iron parameters showed a low serum iron, low iron saturation, elevated serum ferritin, several neurological symptoms, and later discovered abnormal liver function tests, low serum copper and extremely low ceruloplasmin (CP) levels. Initial direct genetic testing showed homozygous variant p.(His63Asp) in <i>HFE</i> and indicated hereditary hemochromatosis (HHC) type 1. The following whole genome sequencing (WGS) revealed the digenic origin of iron overload, since also compound heterozygous variants p.(Tyr890*) and p.(Leu273Pro) in <i>CP</i> were identified, responsible for aceruloplasminemia (ACP). However, clinical significance of p.(His63Asp) is difficult to evaluate due to its low penetrance. Since the patient was intolerant to phlebotomy, chelation therapy with deferasirox was started, which appeared to prevent her liver damage. Based on ACP diagnosis, she has been recently switched to treatment with deferiprone, which has better brain penetrance.</p> Conclusions <p>The presented case of unique digenic iron overload condition (simultaneous HHC and ACP) clarified by WGS, demonstrated multiple diagnostic and therapeutic challenges encountered in rare diseases. It highlights the limitations of targeted genetic testing, while stressing the diagnostic value of comprehensive genomic approaches in complex genotype–phenotype presentations, co-navigating the complicated patient’s and physician’s journey that necessitates multidisciplinary collaboration and use of non-trivial clinical and therapeutic strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Diagnostic Challenges of a Unique Digenic Iron Overload Condition in a Slovak Patient

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月20日

查看全文
  • Helena Glasova,
  • Zuzana Pös,
  • Jan Radvanszky,
  • Andrea Zatkova

摘要

Background and Aims

Iron overload causes symptoms, which can (if not treated) damage organs and systems of the body. We report a Slovakian female patient with chronic anemia and neuropathy due to iron overloading.

Methods and Results

Clinical workup included laboratory investigations, body imaging, and genetic study. Patients’ iron parameters showed a low serum iron, low iron saturation, elevated serum ferritin, several neurological symptoms, and later discovered abnormal liver function tests, low serum copper and extremely low ceruloplasmin (CP) levels. Initial direct genetic testing showed homozygous variant p.(His63Asp) in HFE and indicated hereditary hemochromatosis (HHC) type 1. The following whole genome sequencing (WGS) revealed the digenic origin of iron overload, since also compound heterozygous variants p.(Tyr890*) and p.(Leu273Pro) in CP were identified, responsible for aceruloplasminemia (ACP). However, clinical significance of p.(His63Asp) is difficult to evaluate due to its low penetrance. Since the patient was intolerant to phlebotomy, chelation therapy with deferasirox was started, which appeared to prevent her liver damage. Based on ACP diagnosis, she has been recently switched to treatment with deferiprone, which has better brain penetrance.

Conclusions

The presented case of unique digenic iron overload condition (simultaneous HHC and ACP) clarified by WGS, demonstrated multiple diagnostic and therapeutic challenges encountered in rare diseases. It highlights the limitations of targeted genetic testing, while stressing the diagnostic value of comprehensive genomic approaches in complex genotype–phenotype presentations, co-navigating the complicated patient’s and physician’s journey that necessitates multidisciplinary collaboration and use of non-trivial clinical and therapeutic strategies.